235 related articles for article (PubMed ID: 20357145)
41. DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice.
Grant GJ; Barenholz Y; Piskoun B; Bansinath M; Turndorf H; Bolotin EM
Pharm Res; 2001 Mar; 18(3):336-43. PubMed ID: 11442274
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and safety of liposomal bupivacaine after local infiltration in healthy Chinese adults: a phase 1 study.
Cheung BM; Ng PY; Liu Y; Zhou M; Yu V; Yang J; Wang NQ
BMC Anesthesiol; 2021 Jul; 21(1):197. PubMed ID: 34315419
[TBL] [Abstract][Full Text] [Related]
43. Liposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient.
Mowat JJ; Mok MJ; MacLeod BA; Madden TD
Anesthesiology; 1996 Sep; 85(3):635-43. PubMed ID: 8853095
[TBL] [Abstract][Full Text] [Related]
44. Absorption of Bupivacaine after Administration of a Lozenge as Topical Treatment for Pain from Oral Mucositis.
Mogensen S; Sverrisdóttir E; Sveinsdóttir K; Treldal C; Jensen K; Jensen AB; Kristensen CA; Jacobsen J; Kreilgaard M; Petersen J; Andersen O
Basic Clin Pharmacol Toxicol; 2017 Jan; 120(1):71-78. PubMed ID: 27430990
[TBL] [Abstract][Full Text] [Related]
45. Blood bupivacaine concentrations after pecto-serratus and serratus anterior plane injections of plain and liposomal bupivacaine in robotically-assisted mitral valve surgery: Sub-study of a randomized trial.
Alfirevic A; Almonacid-Cardenas F; Yalcin EK; Shah K; Kelava M; Sessler DI; Turan A
J Clin Anesth; 2024 Aug; 95():111470. PubMed ID: 38604047
[TBL] [Abstract][Full Text] [Related]
46. Prolongation of epidural anaesthesia in dogs with bupivacaine in a lipid emulsion.
Franquelo C; Toledo A; Manubens J; Cristòfol C; Valladares JE; Arboix M
Vet Rec; 2000 Oct; 147(17):477-80. PubMed ID: 11093399
[TBL] [Abstract][Full Text] [Related]
47. Bupivacaine liposome injectable suspension: a new approach to postsurgical pain.
Owen RT
Drugs Today (Barc); 2013 Aug; 49(8):475-82. PubMed ID: 23977664
[TBL] [Abstract][Full Text] [Related]
48. Neurological and histological outcomes after subarachnoid injection of a liposomal bupivacaine suspension in pigs: a pilot study.
Zel J; Hadzic A; Cvetko E; Seliskar A; Damjanovska M; Kuroda MM; Sega Jazbec S; Stopar Pintaric T
Br J Anaesth; 2019 Mar; 122(3):379-387. PubMed ID: 30770056
[TBL] [Abstract][Full Text] [Related]
49. Bupivacaine extended release liposome injection does not prolong QTc interval in a thorough QT/QTc study in healthy volunteers.
Naseem A; Harada T; Wang D; Arezina R; Lorch U; Onel E; Camm AJ; Taubel J
J Clin Pharmacol; 2012 Sep; 52(9):1441-7. PubMed ID: 22058388
[No Abstract] [Full Text] [Related]
50. Estimated plasma bupivacaine concentration after single dose and eight-hour continuous intra-articular infusion of bupivacaine in normal dogs.
Bubenik L; Hosgood G; Barker S; Hicks M; Serra V; Stout R
Vet Surg; 2007 Dec; 36(8):783-91. PubMed ID: 18067620
[TBL] [Abstract][Full Text] [Related]
51. Biodistribution of liposome-associated bupivacaine after extradural administration to rabbits.
Boogaerts JG; Lafont ND; Carlino S; Noel E; Raynal P; Goffinet G; Legros FJ
Br J Anaesth; 1995 Sep; 75(3):319-25. PubMed ID: 7547051
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetic Profile and Tolerability of Liposomal Bupivacaine Following a Repeated Dose via Local Subcutaneous Infiltration in Healthy Volunteers.
Rice D; Heil JW; Biernat L
Clin Drug Investig; 2017 Mar; 37(3):249-257. PubMed ID: 28120158
[TBL] [Abstract][Full Text] [Related]
53. New formulations of bupivacaine for the treatment of postoperative pain: liposomal bupivacaine and SABER-Bupivacaine.
Skolnik A; Gan TJ
Expert Opin Pharmacother; 2014 Aug; 15(11):1535-42. PubMed ID: 24992382
[TBL] [Abstract][Full Text] [Related]
54. Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits.
Malinovsky JM; Benhamou D; Alafandy M; Mussini JM; Coussaert C; Couarraze G; Pinaud M; Legros FJ
Anesth Analg; 1997 Dec; 85(6):1331-6. PubMed ID: 9390603
[TBL] [Abstract][Full Text] [Related]
55. Recent advances in the pharmacokinetics of local anaesthetics. Long-acting amide enantiomers and continuous infusions.
Thomas JM; Schug SA
Clin Pharmacokinet; 1999 Jan; 36(1):67-83. PubMed ID: 9989343
[TBL] [Abstract][Full Text] [Related]
56. Hemodynamic Instability and Lipid Emulsion Resuscitation After Subcutaneous Injection of a Liposomal Bupivacaine Admixture: A Case Report.
Tran BW; Liebman ST; Reichman TW; Scott MJ
A A Pract; 2019 Apr; 12(7):223-225. PubMed ID: 30199400
[TBL] [Abstract][Full Text] [Related]
57. Dexamethasone prolongs local analgesia after subcutaneous infiltration of bupivacaine microcapsules in human volunteers.
Holte K; Werner MU; Lacouture PG; Kehlet H
Anesthesiology; 2002 Jun; 96(6):1331-5. PubMed ID: 12170044
[TBL] [Abstract][Full Text] [Related]
58. Liposomal bupivacaine as a single-injection peripheral nerve block: a dose-response study.
Ilfeld BM; Malhotra N; Furnish TJ; Donohue MC; Madison SJ
Anesth Analg; 2013 Nov; 117(5):1248-56. PubMed ID: 24108252
[TBL] [Abstract][Full Text] [Related]
59. Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep.
Le Corre P; Estèbe JP; Clément R; Du Plessis L; Chevanne F; Ecoffey C; Le Verge R
Int J Pharm; 2002 May; 238(1-2):191-203. PubMed ID: 11996823
[TBL] [Abstract][Full Text] [Related]
60. The Duration of Nerve Block from Local Anesthetic Formulations in Male and Female Rats.
Cullion K; Petishnok LC; Ji T; Zurakowski D; Kohane DS
Pharm Res; 2019 Nov; 36(12):179. PubMed ID: 31705417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
